| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Departments of Laboratory Medicine and Pathology (C.L.H.S., T.J.S., R.J.S., S.K.G.G.), Medicine, Division of Endocrinology (S.K.G.G.), and Diagnostic Radiology (C.C.R.), Mayo Clinic, Rochester, MN 55905; Department of Surgery, Division of Surgical Oncology and Endocrine Surgery (E.P.C.), Vanderbilt-Ingram Cancer Center, Nashville, TN, 37232; and Jackson Thyroid and Endocrine Clinic, P.L.L.C. (J.W.S.), Jackson, MS, 39216
* To whom correspondence should be addressed. E-mail: grebe.stefan{at}mayo.edu.
Context: Clinically enlarged cervical lymph nodes in patients with a history of thyroid cancer are usually assessed by fine-needle aspiration biopsy (FNAB) followed by cytology with or without tissue core. Thyroglobulin (Tg) is frequently elevated in malignant FNAB needle-wash specimens and may possibly augment or replace cytology. Furthermore, the combination of undetectable serum Tg and an innocuous ultrasound might altogether obviate the need for biopsy.
Objectives: (1) Determine an appropriate diagnostic cutoff for Tg levels in FNAB; (2) assess the diagnostic performance at this cutoff; and (3) compare serum Tg and FNAB needle-wash Tg levels to determine if serum Tg levels predict positive Tg FNAB.
Design: Retrospective study of 122 FNAB samples in 88 athyrotic thyroid cancer patients.
Results: Fifty of 52 (96.2%) non-malignant FNAB samples had Tg
1 ng/mL. All 70 malignant FNAB had Tg >1 ng/mL. Of 103 specimens with diagnostic cytology, 5 (4.9%) had discordant Tg results; in 4 of these FNAB Tg was concordant with the final diagnosis. Eighteen of 19 (94.7%) FNAB with non-diagnostic (N=16) or absent (N=3) cytology were correctly classified by FNAB needle-wash Tg. Undetectable (<0.1 ng/mL) serum Tg was associated with a negative diagnosis in 21 of 23 (91.7%) biopsies; the 2 cancer-positives were both serum Tg-autoantibody (TgAb) positive and classified as suspicious by ultrasonography.
Conclusions: Nodal FNAB needle-wash Tg measurements complement cytology in thyroid cancer follow-up, and might substitute for it. The combination of unremarkable ultrasonography and an undetectable serum Tg in TgAb-negative patients might obviate the need for FNAB.
This article has been cited by other articles:
![]() |
A.-L. Borel, R. Boizel, P. Faure, G. Barbe, J. Boutonnat, N. Sturm, D. Seigneurin, I. Bricault, J.-P. Caravel, P. Chaffanjon, et al. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer Eur. J. Endocrinol., May 1, 2008; 158(5): 691 - 698. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |